Live Breaking News & Updates on Department Of Oncologic Sciences

Stay updated with breaking news from Department of oncologic sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Eroglu on Addressing Unmet Needs in Mutant Melanoma

Zeynep Eroglu, MD, discusses a phase 1/2 trial that evaluated ceritinib alone and in combination with trametinib in patients with mutant melanoma. ....

Zeynep-eroglu , Moffitt-cancer-center , Department-of-oncologic-sciences , Department-of-cutaneous-oncology , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college , Moffitt-cancer-center , Melanoma-amp-skin-cancer , Onclive-tv ,

Dr Eroglu on Ceritinib With or Without Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses the efficacy and safety of ceritinib as monotherapy and in combination with trametinib in pretreated advanced melanoma. ....

Zeynep-eroglu , Department-of-cutaneous-oncology , Moffitt-cancer-center , Department-of-oncologic-sciences , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college , Pretreated-advanced-melanoma , Trametinib , Ceritinib ,

Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma. ....

Zeynep-eroglu , Keiran-smalley , Moffitt-cancer-center , Department-of-oncologic-sciences , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college , Melanoma , Ceritinib-and-trametinib- , D , Taacr ,

Dr Eroglu on the Safety Profile of Ceritinib Plus Trametinib in Advanced Melanoma

Zeynep Eroglu, MD, discusses the safety profile of ceritinib plus trametinib in pretreated metastatic melanoma. ....

Zeynep-eroglu , University-of-south-florida , Moffitt-cancer-center , Department-of-oncologic-sciences , Department-of-cutaneous-oncology , Morsani-college-of-medicine , Cutaneous-oncology , Oncologic-sciences , South-florida , Morsani-college , Melanoma , Skin-cancer

Dr Eroglu on Future Steps for Assessing Ceritinib Plus Trametinib in Metastatic Melanoma

Zeynep Eroglu, MD, discusses future steps for assessing ceritinib in combination with trametinib in patients with metastatic melanoma. ....

Zeynep-eroglu , Department-of-oncologic-sciences , Department-of-cutaneous-oncology , Moffitt-cancer-center , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college ,